The US Food and Drug Administration (FDA) has approved Aurobindo Pharma Ltd’s application to market generic ampicillin sodium in the US market. The regulator has approved the pharmaceutical company’s application to market the drug in injection form, in six dosage strengths of 10g, 1g, 2g, 125mg, 250mg and 500mg.
indiabusinessview - Business News, Financial News, Analysis, Commentary, Views, Opinion
indiabusinessview (https://indiabusinessview.com/tag/aurobindo_pharma/)